Laevoroc Oncology: Funding, Investors & Team (Sep 2026)
Laevoroc Oncology is to leverage word-class technologies, extensive R&D, and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Laevoroc Oncology has raised $1.1M across 1 funding round on record, the most recent an undisclosed round of $1.1M announced in May 2021.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Laevoroc Oncology Company Profile and Key Stats
Latest funding round on record: May 2021.
Laevoroc Oncology Funding Rounds
Laevoroc Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Laevoroc Oncology Funding Compared to Other Health Care Startups
Laevoroc Oncology's latest round of $1.1M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Laevoroc Oncology in Health Care and Hünenberg
Companies Similar to Laevoroc Oncology
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Laevoroc Oncology Funding FAQs
What does Laevoroc Oncology do?
Laevoroc Oncology is to leverage word-class technologies, extensive R&D, and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
How much funding has Laevoroc Oncology raised?
Laevoroc Oncology has raised $1.1M across 1 round on record. The most recent is an undisclosed round of $1.1M announced in May 2021.
When did Laevoroc Oncology last raise funding?
Laevoroc Oncology's most recent funding round on record is an undisclosed round of $1.1M, announced in May 2021.
Who is the CEO of Laevoroc Oncology?
Thomas Mehrling is listed as CEO at Laevoroc Oncology.
Where is Laevoroc Oncology headquartered?
Laevoroc Oncology is based in Hünenberg, Zug, Switzerland.
How many employees does Laevoroc Oncology have?
Laevoroc Oncology is in the 1-10 employee band.
How does Laevoroc Oncology's funding compare to other Health Care startups?
Laevoroc Oncology's latest round of $1.1M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Laevoroc Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Laevoroc Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.